| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1600341.0AGB201600341D0 (en) | 2016-01-08 | 2016-01-08 | Diversity scaffolds |
| GBGB1621070.0AGB201621070D0 (en) | 2016-12-12 | 2016-12-12 | Diversity scaffolds |
| PCT/EP2017/050337WO2017118761A1 (en) | 2016-01-08 | 2017-01-09 | Binding members with altered diversity scaffold domains |
| Publication Number | Publication Date |
|---|---|
| SG11201805493YAtrue SG11201805493YA (en) | 2018-07-30 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201805493YASG11201805493YA (en) | 2016-01-08 | 2017-01-09 | Binding members with altered diversity scaffold domains |
| Country | Link |
|---|---|
| US (1) | US20190256840A1 (en) |
| EP (2) | EP3277810B8 (en) |
| JP (2) | JP7308505B2 (en) |
| KR (1) | KR20180100132A (en) |
| CN (1) | CN108473987B (en) |
| AU (1) | AU2017205706B2 (en) |
| BR (1) | BR112018013883A2 (en) |
| CA (1) | CA3010231A1 (en) |
| GB (1) | GB2562933B (en) |
| SG (1) | SG11201805493YA (en) |
| WO (1) | WO2017118761A1 (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102423377B1 (en) | 2013-08-05 | 2022-07-25 | 트위스트 바이오사이언스 코포레이션 | De novo synthesized gene libraries |
| US10669304B2 (en) | 2015-02-04 | 2020-06-02 | Twist Bioscience Corporation | Methods and devices for de novo oligonucleic acid assembly |
| US9981239B2 (en) | 2015-04-21 | 2018-05-29 | Twist Bioscience Corporation | Devices and methods for oligonucleic acid library synthesis |
| CA2998169A1 (en) | 2015-09-18 | 2017-03-23 | Twist Bioscience Corporation | Oligonucleic acid variant libraries and synthesis thereof |
| KR102794025B1 (en) | 2015-09-22 | 2025-04-09 | 트위스트 바이오사이언스 코포레이션 | Flexible substrates for nucleic acid synthesis |
| EP3384077A4 (en) | 2015-12-01 | 2019-05-08 | Twist Bioscience Corporation | FUNCTIONALIZED SURFACES AND THEIR PREPARATION |
| SG11201901563UA (en) | 2016-08-22 | 2019-03-28 | Twist Bioscience Corp | De novo synthesized nucleic acid libraries |
| US10417457B2 (en) | 2016-09-21 | 2019-09-17 | Twist Bioscience Corporation | Nucleic acid based data storage |
| EA201991262A1 (en) | 2016-12-16 | 2020-04-07 | Твист Байосайенс Корпорейшн | LIBRARIES OF OPTIONS OF IMMUNOLOGICAL SYNAPSIS AND THEIR SYNTHESIS |
| CN110892485B (en) | 2017-02-22 | 2024-03-22 | 特韦斯特生物科学公司 | Nucleic acid-based data storage |
| CA3056388A1 (en) | 2017-03-15 | 2018-09-20 | Twist Bioscience Corporation | Variant libraries of the immunological synapse and synthesis thereof |
| MY206158A (en) | 2017-05-24 | 2024-12-02 | Novartis Ag | Antibody-cytokine engrafted proteins and methods of use in the treatment of cancer |
| WO2018231864A1 (en) | 2017-06-12 | 2018-12-20 | Twist Bioscience Corporation | Methods for seamless nucleic acid assembly |
| IL271205B2 (en) | 2017-06-12 | 2025-02-01 | Twist Bioscience Corp | Methods for seamless nucleic acid assembly |
| US11407837B2 (en) | 2017-09-11 | 2022-08-09 | Twist Bioscience Corporation | GPCR binding proteins and synthesis thereof |
| KR102637566B1 (en) | 2017-10-20 | 2024-02-16 | 트위스트 바이오사이언스 코포레이션 | Heated nanowells for polynucleotide synthesis |
| SG11202006460SA (en) | 2018-01-04 | 2020-08-28 | Twist Bioscience Corp | Dna-based digital information storage |
| EP3814497A4 (en) | 2018-05-18 | 2022-03-02 | Twist Bioscience Corporation | POLYNUCLEOTIDES, REAGENTS, AND METHODS FOR NUCLEIC ACID HYBRIDIZATION |
| CN109106942B (en)* | 2018-09-18 | 2019-11-22 | 深圳瑞健生物科技有限公司 | Application of a polypeptide capable of passing through the blood-brain barrier in the preparation of medicines |
| CN119708086A (en) | 2018-12-26 | 2025-03-28 | 特韦斯特生物科学公司 | Highly accurate de novo polynucleotide synthesis |
| US11492727B2 (en) | 2019-02-26 | 2022-11-08 | Twist Bioscience Corporation | Variant nucleic acid libraries for GLP1 receptor |
| CN113785057A (en) | 2019-02-26 | 2021-12-10 | 特韦斯特生物科学公司 | Variant nucleic acid libraries for antibody optimization |
| WO2020257612A1 (en) | 2019-06-21 | 2020-12-24 | Twist Bioscience Corporation | Barcode-based nucleic acid sequence assembly |
| WO2021061829A1 (en) | 2019-09-23 | 2021-04-01 | Twist Bioscience Corporation | Variant nucleic acid libraries for crth2 |
| WO2021061842A1 (en) | 2019-09-23 | 2021-04-01 | Twist Bioscience Corporation | Variant nucleic acid libraries for single domain antibodies |
| EP4384614A4 (en)* | 2021-08-12 | 2025-07-02 | Univ Hong Kong | MATERIALS AND METHODS FOR THE COMPLETE DEFINITION OF ADAPTIVE IMMUNE RESPONSES |
| CN115035947B (en)* | 2022-06-10 | 2023-03-10 | 水木未来(北京)科技有限公司 | Protein structure modeling method and device, electronic device and storage medium |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4275149A (en) | 1978-11-24 | 1981-06-23 | Syva Company | Macromolecular environment control in specific receptor assays |
| US4318980A (en) | 1978-04-10 | 1982-03-09 | Miles Laboratories, Inc. | Heterogenous specific binding assay employing a cycling reactant as label |
| GB9206318D0 (en) | 1992-03-24 | 1992-05-06 | Cambridge Antibody Tech | Binding substances |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| US6172197B1 (en) | 1991-07-10 | 2001-01-09 | Medical Research Council | Methods for producing members of specific binding pairs |
| US6492160B1 (en) | 1991-05-15 | 2002-12-10 | Cambridge Antibody Technology Limited | Methods for producing members of specific binding pairs |
| US5858657A (en) | 1992-05-15 | 1999-01-12 | Medical Research Council | Methods for producing members of specific binding pairs |
| US5962255A (en) | 1992-03-24 | 1999-10-05 | Cambridge Antibody Technology Limited | Methods for producing recombinant vectors |
| DE69230142T2 (en) | 1991-05-15 | 2000-03-09 | Cambridge Antibody Technology Ltd. | METHOD FOR PRODUCING SPECIFIC BINDING PAIRS |
| US6225447B1 (en) | 1991-05-15 | 2001-05-01 | Cambridge Antibody Technology Ltd. | Methods for producing members of specific binding pairs |
| ES2136092T3 (en) | 1991-09-23 | 1999-11-16 | Medical Res Council | PROCEDURES FOR THE PRODUCTION OF HUMANIZED ANTIBODIES. |
| ES2227512T3 (en) | 1991-12-02 | 2005-04-01 | Medical Research Council | PRODUCTION OF ANTIBODIES AGAINST SELF-ANTIGENS FROM REPERTORIES OF ANTIBODY SEGMENTS FIXED IN A PHOTO. |
| US5872215A (en) | 1991-12-02 | 1999-02-16 | Medical Research Council | Specific binding members, materials and methods |
| US5733743A (en) | 1992-03-24 | 1998-03-31 | Cambridge Antibody Technology Limited | Methods for producing members of specific binding pairs |
| US7396917B2 (en)* | 2000-12-05 | 2008-07-08 | Alexion Pharmaceuticals, Inc. | Rationally designed antibodies |
| ATE544785T1 (en) | 2000-12-05 | 2012-02-15 | Alexion Pharma Inc | RATIONALLY DESIGNED ANTIBODIES |
| EP1660534A2 (en)* | 2003-08-22 | 2006-05-31 | MedImmune, Inc. | Humanization of antibodies |
| TWI333977B (en)* | 2003-09-18 | 2010-12-01 | Symphogen As | Method for linking sequences of interest |
| EP1709972B1 (en)* | 2005-04-05 | 2011-06-15 | Affimed Therapeutics AG | Use of an antibody against the laminin receptor or laminin receptor precursor for the diagnosis of cancer |
| EP2271758B1 (en) | 2008-04-14 | 2018-09-12 | Innovative Targeting Solutions Inc. | Sequence diversity generation in immunoglobulins |
| WO2010017103A2 (en)* | 2008-08-04 | 2010-02-11 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Servic | Fully human anti-human nkg2d monoclonal antibodies |
| US8921281B2 (en)* | 2009-05-20 | 2014-12-30 | Novimmune S.A. | Synthetic polypeptide libraries and methods for generating naturally diversified polypeptide variants |
| AU2011326164B2 (en)* | 2010-11-08 | 2016-05-05 | The Board Of Trustees Of The Leland Stanford Junior University | Fusion proteins comprising an engineered knottin peptide and uses thereof |
| JP6684490B2 (en)* | 2012-01-09 | 2020-04-22 | ザ・スクリップス・リサーチ・インスティテュート | Ultralong complementarity determining regions and uses thereof |
| EP2825653A4 (en) | 2012-03-14 | 2016-01-20 | Innovative Targeting Solutions Inc | Generating targeted sequence diversity in fusion proteins |
| WO2014063012A1 (en)* | 2012-10-19 | 2014-04-24 | The Board Of Trustees Of The Leland Stanford Junior University | Conjugated knottin mini-proteins containing non-natural amino acids |
| GB201302597D0 (en) | 2013-02-14 | 2013-04-03 | Univ Leeds | Novel Synthetic Proteins |
| JP2016506974A (en)* | 2013-02-15 | 2016-03-07 | エスバテック − ア ノバルティスカンパニー エルエルシー | Acceptor framework for CDR grafting |
| CN105814074B (en)* | 2013-07-18 | 2020-04-21 | 图鲁斯生物科学有限责任公司 | Humanized antibodies with ultralong complementarity determining regions |
| WO2015017146A2 (en)* | 2013-07-18 | 2015-02-05 | Fabrus, Inc. | Antibodies with ultralong complementarity determining regions |
| GB201407852D0 (en)* | 2014-05-02 | 2014-06-18 | Iontas Ltd | Preparation of libraries od protein variants expressed in eukaryotic cells and use for selecting binding molecules |
| GB201720351D0 (en)* | 2017-12-06 | 2018-01-17 | Iontas Ltd | Selecting for developability in drug discovery |
| Publication number | Publication date |
|---|---|
| JP7308505B2 (en) | 2023-07-14 |
| RU2018123301A (en) | 2020-02-10 |
| GB2562933A (en) | 2018-11-28 |
| BR112018013883A2 (en) | 2018-12-18 |
| GB201812040D0 (en) | 2018-09-05 |
| KR20180100132A (en) | 2018-09-07 |
| CN108473987B (en) | 2024-01-02 |
| CN108473987A (en) | 2018-08-31 |
| RU2018123301A3 (en) | 2020-06-30 |
| WO2017118761A1 (en) | 2017-07-13 |
| EP3277810A1 (en) | 2018-02-07 |
| CA3010231A1 (en) | 2017-07-13 |
| JP2022084834A (en) | 2022-06-07 |
| JP2019505206A (en) | 2019-02-28 |
| US20190256840A1 (en) | 2019-08-22 |
| EP3277810B8 (en) | 2020-07-15 |
| AU2017205706B2 (en) | 2022-10-20 |
| EP3277810B1 (en) | 2020-05-27 |
| GB2562933B (en) | 2022-06-29 |
| AU2017205706A1 (en) | 2018-08-16 |
| GB2562933A8 (en) | 2018-12-19 |
| EP3786292A1 (en) | 2021-03-03 |
| JP7539018B2 (en) | 2024-08-23 |
| Publication | Publication Date | Title |
|---|---|---|
| SG11201805493YA (en) | Binding members with altered diversity scaffold domains | |
| SG11201807252QA (en) | Anti-lag-3 antibodies | |
| SG11201809857TA (en) | Anti-CTLA-4 Antibodies | |
| SG11201910019PA (en) | Microorganisms and methods for producing cannabinoids and cannabinoid derivatives | |
| SG11201908820VA (en) | Novel heterocyclic derivatives useful as shp2 inhibitors | |
| SG11201811184UA (en) | Lag -3 binding members | |
| SG11201909949XA (en) | Targeted immunotolerance | |
| SG11201805449PA (en) | Methods of making chimeric antigen receptor -expressing cells | |
| SG11201907857RA (en) | Edible and biodegradable utensils | |
| SG11201805532XA (en) | Multivalent and multispecific 41bb-binding fusion proteins | |
| SG11201907210YA (en) | Policy communication via control plane signaling | |
| SG11201811431VA (en) | Multispecific antibodies against cd40 and cd137 | |
| SG11201805422WA (en) | Multivalent and multispecific ox40-binding fusion proteins | |
| SG11201900634VA (en) | Chimeric antigen receptor | |
| SG11201903857UA (en) | Antibodies to pd-1 and uses thereof | |
| SG11201908280SA (en) | "chimeric molecules and uses thereof" | |
| SG11201808724SA (en) | Anti-tim-3 antibodies and compositions | |
| SG11201903012RA (en) | Anti-c1s antibodies and methods of use thereof | |
| SG11201808797XA (en) | T cell receptors | |
| SG11201908675PA (en) | Computer-implemented system and method for performing transaction mixing on a blockchain | |
| SG11201810983PA (en) | Novel heterocyclic derivatives useful as shp2 inhibitors | |
| SG11201809374VA (en) | Cd40l-fc fusion polypeptides and methods of use thereof | |
| SG11201810887UA (en) | Baff-r targeted chimeric antigen receptor-modified t-cells and uses thereof | |
| SG11201807474SA (en) | Compositions comprising coformulation of anti-pd-l1 and anti-ctla-4 antibodies | |
| SG11201805204WA (en) | Nicotine particle capsule |